Jim Pearson and Joseph Mark Reunite to Expand HoloMD's AI-Driven Psychiatry Platform for Healthcare Innovation

Written by Emily J. Thompson, Senior Investment Analyst
Source: Businesswire
Updated: Oct 28 2025
0mins
AI Stock Picker
  • Leadership Appointment: HoloMD has appointed Jim Pearson as Executive Chairman, reuniting him with collaborator Joseph Mark, as they aim to tackle significant challenges in behavioral health using AI technology.

  • Addressing Mental Health Needs: The platform aims to bridge the gap in mental health care by providing ongoing, personalized support through its AI-driven virtual psychiatric assistant, Dr. Holo™, which enhances patient engagement and clinician insights.

  • AI-Powered Benefits: HoloMD's AI platform is designed to improve patient outcomes, provide valuable insights for healthcare providers, and enhance operational efficiency for organizations and payers.

  • Company Overview: Founded in July 2024, HoloMD is a HIPAA-compliant company with a patent-pending AI psychiatry platform that focuses on continuous patient engagement and treatment adherence, currently holding multiple patents and trademarks.

About the author

Emily J. Thompson
Preview
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

People Also Watch